{
  "id": "mhgap#risk_safety_6bea9882",
  "content": "contraindicated in individuals with liver disease.\nRemarks y Phenytoin, despite being used as a first-line drug in\ny As ASM choice depends on seizure semiology, some places, has a problematic pharmacokinetic\noutcomes are reported separately for focal onset profile. Phenytoin has associated risks of arrhythmia\nseizures (focal seizures with or without awareness, and hypotension and can be difficult to administer in\nfocal to bilateral tonic-clonic seizures) and adults with comorbid cardiac conditions.\ngeneralized onset tonic-clonic seizures (with or y Most trials excluded women known to be\nwithout other generalized seizure types such as pregnant. Seizures in pregnant women can\nmyoclonus or absence seizures). be due to eclampsia, which requires different\ntreatment strategies.\n81\nMental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders\nResearch gaps Implementation considerations\ny Most of the evidence is from HICs. Further research is y The choice of medicine is affected by a number of\nneeded in LMICs. factors, including seizure semiology, comorbidities,\ny The evidence did not allow for consideration of availability, cost and side-effects.\nadults and children/adolescents as subgroups. y There are feasibility and affordability issues;",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "stress",
      "risk_safety",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General â€” Risk Safety contraindicated in individuals with liver disease.\nRemarks y Phenytoin, despite being used as a first-line drug in\ny As ASM choice depends on seizure semiology, some places, has a problematic pharmacokinetic\noutcomes are reported separately for focal onset profile. Phenytoin has associated risks of arrhythmia\nseizures (focal seizures with or without awareness, and hypotension and can be difficult to administer in\nfocal to bilateral tonic-clonic seizures) and adults with comorbid cardiac conditions.\ngeneralized onset tonic-clonic seizures (with or y Most trials excluded women known to be\nwithout other generalized seizure types such as pregnant. Seizures in pregnant women can\nmyoclonus or absence seizures). be due to eclampsia, which requires different\ntreatment strategies.\n81\nMental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders\nResearch gaps Implementation considerations\ny Most of the evidence is from HICs. Further research is y The choice of medicine is affected by a number of\nneeded in LMICs. factors, including seizure semiology, comorbidities,\ny The evidence did not allow for consideration of availability, cost and side-effects.\nadults and children/adolescents as subgroups. y There are feasibility and affordability issues; Contraindicated in individuals with liver disease. remarks y phenytoin, despite being used as a first-line drug in\ny as asm choice depends on seizure semiology, some places, has a problematic pharmacokinetic\noutcomes are..."
}